Gamma-synuclein, also known as SNCG, is a member of the synuclein family of proteins, which includes alpha-synuclein and beta-synuclein. These proteins are predominantly expressed in the nervous system and have been implicated in the pathogenesis of neurodegenerative diseases, such as Parkinson’s disease and Alzheimer’s disease .
Gamma-synuclein is encoded by the SNCG gene and is also referred to as breast cancer-specific gene 1 protein (BCSG1), persyn, and synoretin . It is abundantly expressed in the brain, particularly in the presynaptic terminals of neurons . Gamma-synuclein has been associated with various cellular functions, including synaptic plasticity and neurotransmitter release. Additionally, mutations and overexpression of gamma-synuclein have been linked to the development of breast tumors .
Polyclonal antibodies are produced by immunizing animals, such as rabbits, with an antigen. In this case, the antigen is gamma-synuclein. The immune system of the rabbit generates a diverse population of antibodies that recognize multiple epitopes on the gamma-synuclein protein. These antibodies are then collected from the rabbit’s serum and purified for use in various research applications .
The polyclonal rabbit anti-human gamma-synuclein antibody is widely used in scientific research for the detection and study of gamma-synuclein in various biological samples. Some common applications include: